vs
Side-by-side financial comparison of IRIDEX CORP (IRIX) and LANDMARK BANCORP INC (LARK). Click either name above to swap in a different company.
LANDMARK BANCORP INC is the larger business by last-quarter revenue ($18.8M vs $14.7M, roughly 1.3× IRIDEX CORP). On growth, LANDMARK BANCORP INC posted the faster year-over-year revenue change (14.0% vs -69.7%). Over the past eight quarters, LANDMARK BANCORP INC's revenue compounded faster (13.1% CAGR vs 11.9%).
IRIDEX Corporation is a global medical technology company that designs, manufactures and distributes advanced laser-based medical devices, primarily serving the ophthalmology and aesthetic medicine sectors. It supplies products to healthcare providers, clinics and medical facilities across North America, Europe, Asia Pacific and other regions, delivering minimally invasive solutions for eye disease treatment and cosmetic procedures.
Landmark Bancorp Inc is a U.S.-based bank holding company operating Landmark National Bank, primarily serving communities across Kansas. It provides a full range of personal and commercial banking services including deposit accounts, residential mortgages, commercial loans, and wealth management solutions, catering to individual consumers, small businesses and local mid-sized enterprises.
IRIX vs LARK — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $14.7M | $18.8M |
| Net Profit | — | $5.1M |
| Gross Margin | 37.2% | — |
| Operating Margin | — | — |
| Net Margin | — | 27.0% |
| Revenue YoY | -69.7% | 14.0% |
| Net Profit YoY | — | 7.8% |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $18.8M | ||
| Q4 25 | $14.7M | $18.7M | ||
| Q3 25 | $12.5M | $18.2M | ||
| Q2 25 | $13.6M | $17.3M | ||
| Q1 25 | $11.9M | $16.5M | ||
| Q4 24 | $12.7M | $15.8M | ||
| Q3 24 | $11.6M | $15.9M | ||
| Q2 24 | $12.6M | $14.7M |
| Q1 26 | — | $5.1M | ||
| Q4 25 | — | $4.7M | ||
| Q3 25 | $-1.6M | $4.9M | ||
| Q2 25 | $-994.0K | $4.4M | ||
| Q1 25 | $-1.7M | $4.7M | ||
| Q4 24 | $-834.0K | $3.3M | ||
| Q3 24 | $-1.9M | $3.9M | ||
| Q2 24 | $-2.7M | $3.0M |
| Q1 26 | — | — | ||
| Q4 25 | 37.2% | — | ||
| Q3 25 | 32.1% | — | ||
| Q2 25 | 34.5% | — | ||
| Q1 25 | 42.5% | — | ||
| Q4 24 | 44.0% | — | ||
| Q3 24 | 37.3% | — | ||
| Q2 24 | 40.7% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | 31.7% | ||
| Q3 25 | -11.3% | 33.4% | ||
| Q2 25 | -6.9% | 30.9% | ||
| Q1 25 | -1.7% | 34.7% | ||
| Q4 24 | -3.9% | 15.2% | ||
| Q3 24 | -16.1% | 30.3% | ||
| Q2 24 | -20.9% | 24.5% |
| Q1 26 | — | 27.0% | ||
| Q4 25 | — | 32.1% | ||
| Q3 25 | -12.6% | 27.1% | ||
| Q2 25 | -7.3% | 25.4% | ||
| Q1 25 | -14.2% | 28.5% | ||
| Q4 24 | -6.6% | 26.5% | ||
| Q3 24 | -16.7% | 24.8% | ||
| Q2 24 | -21.2% | 20.5% |
| Q1 26 | — | — | ||
| Q4 25 | — | $0.66 | ||
| Q3 25 | $-0.09 | $0.85 | ||
| Q2 25 | $-0.06 | $0.75 | ||
| Q1 25 | $-0.10 | $0.81 | ||
| Q4 24 | $-0.05 | $0.47 | ||
| Q3 24 | $-0.12 | $0.68 | ||
| Q2 24 | $-0.16 | $0.52 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $6.0M | $31.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | — |
| Total Assets | $29.2M | $1.6B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $31.9M | ||
| Q4 25 | $6.0M | — | ||
| Q3 25 | $5.6M | — | ||
| Q2 25 | $6.8M | — | ||
| Q1 25 | $7.2M | — | ||
| Q4 24 | $2.4M | — | ||
| Q3 24 | $3.9M | — | ||
| Q2 24 | $4.1M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.0M | — | ||
| Q3 24 | $1.4M | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | $160.6M | ||
| Q3 25 | $4.7M | $155.7M | ||
| Q2 25 | $6.1M | $148.4M | ||
| Q1 25 | $852.0K | $142.7M | ||
| Q4 24 | $2.1M | $136.2M | ||
| Q3 24 | $2.6M | $139.7M | ||
| Q2 24 | $4.2M | $128.3M |
| Q1 26 | — | $1.6B | ||
| Q4 25 | $29.2M | $1.6B | ||
| Q3 25 | $28.4M | $1.6B | ||
| Q2 25 | $31.6M | $1.6B | ||
| Q1 25 | $34.2M | $1.6B | ||
| Q4 24 | $29.1M | $1.6B | ||
| Q3 24 | $30.2M | $1.6B | ||
| Q2 24 | $31.2M | $1.6B |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.48× | — | ||
| Q3 24 | 0.53× | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
